CompBioMed is a European Commission H2020 funded Centre of Excellence focussed on the use and development of computational methods for biomedical applications. It has users within academia, industry and clinical environments and is working to train more people in the use of its products and methods. CompBioMed started on 2016 and has been extended on October 2019 for another 4 years until 2023.

visit the project website


La Red de Excelencia de Bioinformática Traslacional, TransBioNet, está coordinada por el Instituto Nacional de Bioinformática, plataforma tecnológica del Instituto de Salud Carlos III. La red está integrada por más de 35 unidades de apoyo bioinformático a lo largo del país entre las que está el GRIB.

More information about TransBioNet

EU-OPENSCREEN (EU-OS), the European Research Infrastructure of Open Screening Platforms for Chemical Biology, builds a distributed organization of national screening and chemistry facilities, a common database, and a central headquarter that manages the joint compound collection and coordinates project flow and training. It provides world-class services to academia and industry in the fields of small molecule screening and medicinal chemistry. The project is funded by H2020 for the period 2019-2023.

Visit EU-OS DRIVE website


A novel paradigm for effective and safer treatment of schizophrenia: biased (ANT) agonists with a characterized polypharmacological profile. The project is funded by the H2020 ERA-NET NEURON project for the period 2019-2021 and is coordinated by the GRIB.


The project EOSC-Life aims to create an open collaborative digital space for life science in the European Open Science Cloud (EOSC). EOSC-Life brings together the 13 european research infrastructures in the Health and Food domain of the ESFRI Roadmap and is funded by H2020 for the period 2019-2023.

Read news about the project


The project FAIRPlus aims to improve data management and data governance in European health research. The project aims to increase the discovery, accessibility and reusability of data from selected projects funded by the EU's Innovative Medicine Initiative (IMI), and internal data from pharmaceutical industry partners. It will also organise training for data scientists in academia, SMEs and pharmaceutical companies to enable wider adoption of best practises in life science data management. The project is funded by the Innovative Medicines Initiative (IMI2) together with the pharmaceutical industry for the period 2019-2021.

Visit project website



The project eTRANSAFE: Enhancing Translational Safety Assessment through Integrative Knowledge Management, aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the security in drug development process. The project is funded by the Innovative Medicines Initiative (IMI 2) together with the pharmaceutical industry for the period 2017-2022 and is coordinated by the GRIB. 

Visit project website


The european project TransQSTTranslational Quantitative Systems Toxicology aims to develop novel computational approaches using the best available data from the public and private domains to address the problems of drug safety. Funded by IMI2 for the period 2017-2021.

Visit project


European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment. European project funded by H2020 for the period 2017-2021. 

more info at European Society of Cardiology website

project webpage


The aim of the project ELIXIR-EXCELERATE is to accelerate the implementation of Europe's life-science data infrastructure. European project funded by H2020 for the period 2015-2019.

More info about this project

Site Information